RSS

DePuy Synthes

New clinical results from orthopaedics device company DePuy Synthes show that the company’s Corail Hip System Femoral Stems are associated with a lower revision risk compared to similar available devices. more

Devices

The North American vertebroplasty market, is set to see a steep decline from an estimated $72 million in 2016 to around $29.4 million by 2023, more

News

DePuy Synthes Products has acquired 3D printing technology from Tissue Regeneration Systems (TRS). more

News